Market Place
Sourcing Support
Lilly, Pfizer stop study of arthritis drug after FDA rejection
27 Oct 2021 //
FIERCEBIOTECH
Lilly Reports Robust Third-Quarter 2021 Financial Results
25 Oct 2021 //
PRNEWSWIRE
Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer
23 Sep 2021 //
RAPS
US FDA accepts regulatory submission of Pfizer & Eli Lilly`s tanezumab
03 Mar 2020 //
PHARMABIZ
U.S. FDA Accepts Regulatory Sub for Tanezumab, a Potential First-in-Class
02 Mar 2020 //
PRESS RELEASE
Lilly Bio-Medicines chief Christi Shaw steps aside, leaving key launches behind
11 Jul 2019 //
FIERCE PHARMA
Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous
22 Apr 2019 //
BIOPHARMADIVE
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
20 Apr 2019 //
REUTERS
Pfizer & Lilly Announce Top-Line Results Long-Term Phase 3 Study of Tanezumab
18 Apr 2019 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.